Health In Tech HIT
- Market cap
- $36.9M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.1×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $32.8M
- +23% on a year ago
- Net margin
- −12.0%
- Free cash flow yield
- n/m
- not a meaningful number
Health In Tech trades at 1.1× sales. Its trailing earnings are negative, so it has no PE. Revenue was $32.8M over the last twelve months, up 23% on a year earlier with a −12% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| $5.1M | $5M | $4.5M | $4.9M | $8M+56% | $9.3M+86% | $8.5M+90% | $7.5M+53% | $8.8M+9% | $8.1M−14% | |
| Cost of revenue | $989.9K | $974.7K | $979.6K | $1.1M | $2.7M+169% | $3M+208% | $3.3M+242% | $3.4M+205% | $4.3M+60% | $4.1M+38% |
| Gross profit | $4.1M | $4M | $3.5M | $3.8M | $5.4M+30% | $6.3M+57% | $5.1M+48% | $4.1M+9% | $4.5M−16% | $3.9M−38% |
| R&D | $760.2K | $701.6K | $718.4K | $633.7K | $537.7K−29% | $582.6K−17% | $235.8K−67% | $213.1K−66% | $920.4K+71% | $875.8K+50% |
| SG&A | $3M | $2.8M | $2.3M | $3.5M | $4.3M+43% | $5M+79% | $4.4M+90% | $4.1M+17% | $5.7M+33% | $6.5M+30% |
| $332.4K | $534.9K | $438.9K | −$316.3K | $480.7K+45% | $725.1K+36% | $493.5K+13% | −$170.8K−46% | −$2.2M | −$3.4M | |
| Interest expense | $165K | $165K | $165K | $0 | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | $191.7K | $401.3K | $406.7K | −$110.7K | $684.4K+257% | $833.3K+108% | $600.2K+48% | −$443.7K+301% | −$2.1M | −$3.3M |
| $91.2K | $63.3K | $30.7K | $33.4K | $185.8K+104% | $202.6K+220% | $148K+383% | −$141.2K | −$480.1K | −$809.9K | |
| Net income | $100.5K | $338K | $376.1K | −$144.2K | $498.6K+396% | $630.6K+87% | $452.2K+20% | −$302.6K+110% | −$1.6M | −$2.5M |
| $0.00 | $0.01 | $0.01 | $0.00 | $0.01 | $0.01+0% | $0.01+0% | −$0.01 | −$0.03 | −$0.04 | |
| 51.8M | 51.8M | 51.8M | 52M | 57M+10% | 55.6M+8% | 58.8M+14% | 56.9M+9% | 57.4M+1% | 62.8M+13% |
Operating income: 9 periods, Q1 FY24 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 3 periods, Q1 FY24 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY24 and Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial Services nearest Health In Tech's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| HITHealth In Tech | $36.9M | n/m | 52.2× | 1.1× | +23% | −12.0% | |
| GROWU S Global Investors | $32.3M | 10.9× | 18.7× | 3.1× | +21% | 29.8% | |
| MBBCMarathon Bancorp | $44.2M | 21.9× | 33.5× | n/m | +33% | 19.8% | |
| TCBSTexas Community Bancshares | $49.5M | 14.2× | 22.8× | n/m | +14% | 19.1% | |
| ATCHAtlasClear | $24M | 15.8× | 17.5× | 1.2× | +85% | 9.8% | |
| RSSSResearch Solutions | $66.2M | 21.8× | 22.2× | 1.4× | −2% | 5.8% | |
| CLSTCatalyst Bancorp | $68.1M | 31.3× | 30.3× | n/m | −2% | 18.0% | |
| VIPVulcan Infrastructure & Power | $19.6M | 17.9× | 24.4× | 0.4× | −14% | 1.0% | |
| BCGBinah Capital | $18.2M | 6.7× | 20.8× | 0.1× | +8% | 2.2% | |
| UBCPUnited Bancorp | $78.7M | 9.9× | 11.1× | n/m | n/m | n/m | |
| HNNAHennessy Advisors | $80.5M | 9.7× | 9.2× | 2.4× | −7% | 24.8% | |
| Peer median | $46.8M | 15.0× | 21.5× | 1.3× | +8% | 18.0% |
More on Health In Tech
Each number over time
Where it ranks
Its groups
About
- Industry
- Insurance - Brokers
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .